BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 56405)

  • 21. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
    Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
    J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell recognition in the mixed lymphocyte response. I. Non-T, radiation-resistant splenic adherent cells are the predominant stimulators in the murine mixed lymphocyte reaction.
    Ahmann GB; Nadler PI; Birnkrant A; Hodes RJ
    J Immunol; 1979 Aug; 123(2):903-9. PubMed ID: 88485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae.
    Harris DP; Jones AG; Wade S; Krahenbuhl JL; Gillis TP; Watson JD
    J Immunol; 1988 Sep; 141(5):1695-700. PubMed ID: 2970509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens.
    Huston DP; Jenkins RN; Gresens SE; Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2198-204. PubMed ID: 3156180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
    Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
    Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineation of Ia:nominal antigen complementary determinants recognized by T cells in studies of gene complementation in response to insulin.
    Lin CC; Hansen TH; Passmore HC; Rosenthal AS; Tse HY; Walsh WD; Kanamori S
    J Immunol; 1984 Jan; 132(1):303-9. PubMed ID: 6197448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking of MLC stimulation by anti-Ia sera: studies with the virus plaque assay.
    Kano S; Bloom BR; Shreffler DC
    J Immunol; 1976 Jul; 117(1):242-5. PubMed ID: 58932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
    Holda JH; Maier T; Claman HN
    J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of (SJL/J x PL/J)F1 hybrid mice to develop immunologic tolerance to V beta 17a+ T cells results in F1 anti-SJL mixed lymphocyte reaction.
    Liu M; Skeen MJ; Fritz RB
    J Immunol; 1990 Jan; 144(1):41-6. PubMed ID: 1688574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y.
    Müllbacher A; Sheena JH; Fierz W; Brenan M
    J Immunol; 1981 Aug; 127(2):686-9. PubMed ID: 6166683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sharing of Ia antigens between species. II. Molecular localization of shared Ia determinants implies the existence of more than one I sublocus of the rat MHC.
    Shinohara N; Lunney JK; Sachs DH
    J Immunol; 1978 Aug; 121(2):637-40. PubMed ID: 79611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific T cell clones restricted to unique F1 major histocompatibility complex determinants. Inhibition of proliferation with monoclonal anti-Ia antibody.
    Sredni B; Matis LA; Lerner EA; Paul WE; Schwartz RH
    J Exp Med; 1981 Mar; 153(3):677-93. PubMed ID: 6166704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
    Hirano T; Nordin AA
    J Immunol; 1976 Dec; 117(6):2226-32. PubMed ID: 62810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex-restricted self recognition. A monoclonal anti-I-Ak reagent blocks helper T cell recognition of self major histocompatibility complex determinants.
    Hodes RJ; Hathcock KS; Singer A
    J Exp Med; 1980 Dec; 152(6):1779-94. PubMed ID: 6161203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent inhibition of IL 2 synthesis and cell proliferation by anti-Ia antibodies in mixed lymphocyte responses to Mls.
    Macphail S; Stutman O
    Eur J Immunol; 1984 Apr; 14(4):318-24. PubMed ID: 6233154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine specificity of a T cell line reactive to bovine insulin.
    Reske-Kunz AB; Rüde E
    J Immunol; 1982 Mar; 128(3):1252-5. PubMed ID: 6173429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic and biochemical studies of the Ia system of the mouse H-2 gene complex. Further evidence for I-C subregion.
    David CS; Cullen SE; Murphy DB
    J Immunol; 1975 Apr; 114(4):1205-9. PubMed ID: 1117139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.